Mary F Malley Selected Research

Pharmaceutical Preparations

1/2011	Cannabinoid CB(1) receptor ligand binding and function examined through mutagenesis studies of F200 and S383.
3/2007	Discovery of (R)-9-ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-a]isoindol- 6(2H)-one, a selective, orally active agonist of the 5-HT(2C) receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mary F Malley Research Topics

Disease

2	Obesity 01/2011 - 03/2007
1	Body Weight (Weight, Body) 03/2007
1	Type 2 Diabetes Mellitus (MODY) 05/2004
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2002

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 01/2011 - 03/2007
1	CannabinoidsIBA 01/2011
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2011
1	Serotonin 5-HT2 Receptor AntagonistsIBA 03/2007
1	Glucagon-Like Peptide 1 (GLP 1)IBA 05/2004
1	Glucose (Dextrose)FDA LinkGeneric 05/2004
1	BMS 189664IBA 01/2002
1	Thrombin FDA Link 01/2002

Therapy/Procedure

1	Therapeutics 03/2007